Adagene (ADAG) Short Interest Ratio & Short Volume $1.59 +0.07 (+4.61%) As of 05/1/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Adagene Short Interest DataAdagene (ADAG) has a short interest of 47,700 shares, representing 0.13% of the float (the number of shares available for trading by the public). This marks a -28.70% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 60,435 shares to cover all short positions.Current Short Interest47,700 sharesPrevious Short Interest66,900 sharesChange Vs. Previous Month-28.70%Dollar Volume Sold Short$76,320.00Short Interest Ratio0.7 Days to CoverLast Record DateApril 15, 2025Outstanding Shares47,110,000 sharesFloat Size35,760,000 sharesShort Percent of Float0.13%Today's Trading Volume15,705 sharesAverage Trading Volume60,435 sharesToday's Volume Vs. Average26% Short Selling Adagene? Sign up to receive the latest short interest report for Adagene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartADAG Short Interest Over TimeADAG Days to Cover Over TimeADAG Percentage of Float Shorted Over Time Adagene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202547,700 shares $76,320.00 -28.7%0.1%0.7 $1.60 3/31/202566,900 shares $102,691.50 +265.6%0.2%1 $1.54 3/15/202518,300 shares $32,416.62 +3.4%0.1%0.3 $1.77 2/28/202517,700 shares $35,577.00 -55.9%0.1%0.2 $2.01 2/15/202540,100 shares $70,576.00 +13.3%0.1%0.5 $1.76 1/31/202535,400 shares $67,260.00 -50.2%0.1%0.4 $1.90 1/15/202571,100 shares $131,179.50 -10.7%0.2%0.7 $1.85 12/31/202479,600 shares $158,404.00 +21.9%0.2%1.3 $1.99 12/15/202465,300 shares $134,518.00 +88.2%0.2%1.1 $2.06 11/30/202434,700 shares $81,024.50 +2,213.3%0.1%0.5 $2.34 Get the Latest News and Ratings for ADAG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adagene and its competitors with MarketBeat's FREE daily newsletter. 11/15/20241,500 shares $3,240.00 -87.8%N/A0 $2.16 10/31/202412,300 shares $35,055.00 -42.5%0.0%0.1 $2.85 10/15/202421,400 shares $51,146.00 -30.7%0.1%0.3 $2.39 9/30/202430,900 shares $68,598.00 +153.3%0.1%0.4 $2.22 9/15/202412,200 shares $42,578.00 -2.4%0.0%0.2 $3.49 8/31/202412,500 shares $35,000.00 -3.9%0.0%0.2 $2.80 8/15/202413,000 shares $33,670.00 +170.8%0.0%0.3 $2.59 7/31/20244,800 shares $11,712.00 -34.3%0.0%0.2 $2.44 7/15/20247,300 shares $19,929.00 -62.9%0.0%0.2 $2.73 6/30/202419,700 shares $60,301.70 +45.9%0.1%0.6 $3.06 6/15/202413,500 shares $36,180.00 +400.0%0.0%0.4 $2.68 5/31/20242,700 shares $6,831.00 -75.7%0.0%0.1 $2.53 5/15/202411,100 shares $29,526.00 -26.5%0.0%0.3 $2.66 4/30/202415,100 shares $34,126.00 +6.3%0.0%0.6 $2.26 4/15/202414,200 shares $36,920.00 +3.7%0.0%0.3 $2.60 3/31/202413,700 shares $38,360.00 -38.6%0.0%0.1 $2.80 3/15/202422,300 shares $63,443.50 +9.9%0.1%0.2 $2.85 2/29/202420,300 shares $64,960.00 -7.3%0.1%0.2 $3.20 2/15/202421,900 shares $76,650.00 -50.9%0.1%0.2 $3.50 1/31/202444,600 shares $163,236.00 +105.5%0.1%0.4 $3.66 1/15/202421,700 shares $68,789.00 -13.9%0.1%0.2 $3.17 12/31/202325,200 shares $48,671.28 -23.2%0.1%0.8 $1.93 12/15/202332,800 shares $50,184.00 +47.8%0.1%1.5 $1.53 11/30/202322,200 shares $38,850.00 +0.5%0.1%1.2 $1.75 11/15/202322,100 shares $30,056.00 +0.9%0.1%1.5 $1.36 10/31/202321,900 shares $29,674.50 -9.5%0.1%1.4 $1.36 10/15/202324,200 shares $34,122.00 -4.0%0.1%1.4 $1.41 9/30/202325,200 shares $38,556.00 +0.4%0.1%1.4 $1.53 9/15/202325,100 shares $35,642.00 -14.0%0.1%1.1 $1.42 8/31/202329,200 shares $39,712.00 +4.3%0.1%1.1 $1.36Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 8/15/202328,000 shares $37,240.00 +42.1%0.1%1.1 $1.33 7/31/202319,700 shares $26,792.00 +8.2%0.1%0.8 $1.36 7/15/202318,200 shares $26,572.00 -34.1%0.0%0.7 $1.46 6/30/202327,600 shares $39,192.00 +200.0%0.1%1.1 $1.42 6/15/20239,200 shares $12,696.00 -48.9%0.0%0.6 $1.38 5/31/202318,000 shares $24,120.00 -8.2%0.0%1.6 $1.34 5/15/202319,600 shares $26,068.00 +108.5%0.1%1.8 $1.33 4/30/20239,400 shares $12,314.00 -9.6%0.0%0.8 $1.31 4/15/202310,400 shares $15,496.00 -28.8%0.0%0.7 $1.49 3/31/202314,600 shares $21,170.00 +44.6%0.0%0.7 $1.45 3/15/202310,100 shares $16,160.00 +23.2%0.0%0.4 $1.60 2/28/20238,200 shares $13,642.34 -10.9%0.0%0.2 $1.66 2/15/20239,200 shares $17,342.00 -24.0%0.0%0.2 $1.89 1/31/202312,100 shares $23,232.00 -38.3%0.0%0.2 $1.92 1/15/202319,600 shares $34,888.00 -59.9%0.1%0.3 $1.78 12/30/202248,900 shares $64,792.50 -63.9%0.1%0.7 $1.33 12/15/2022135,300 shares $178,596.00 +30.9%0.3%2 $1.32 11/30/2022103,400 shares $111,672.00 -7.2%0.3%1.8 $1.08 11/15/2022111,400 shares $132,566.00 +17.8%0.3%2 $1.19 10/31/202294,600 shares $85,140.00 +56.6%0.2%1.5 $0.90 10/15/202260,400 shares $79,124.00 -5.0%0.2%1.2 $1.31 9/30/202263,600 shares $81,408.00 +8.7%0.2%1.3 $1.28 9/15/202258,500 shares $83,070.00 -9.3%0.1%0.8 $1.42 8/31/202264,500 shares $94,170.00 -21.2%0.2%0.7 $1.46 8/15/202281,800 shares $114,520.00 +19.9%0.2%0.9 $1.40 7/31/202268,200 shares $115,258.00 -4.2%0.2%0.9 $1.69 7/15/202271,200 shares $137,772.00 +37.7%0.2%1.1 $1.94 6/30/202251,700 shares $107,019.00 -4.3%0.1%0.8 $2.07 6/15/202254,000 shares $108,000.00 -13.7%0.1%1.1 $2.00 5/31/202262,600 shares $175,280.00 -18.0%0.2%1.9 $2.80 5/15/202276,300 shares $243,397.00 -3.4%0.2%1.9 $3.19 4/30/202279,000 shares $288,350.00 -2.8%0.2%2.1 $3.65 4/15/202281,300 shares $301,623.00 +6.4%0.2%2.2 $3.71 3/31/202276,400 shares $267,400.00 -11.5%0.2%2.2 $3.50 3/15/202286,300 shares $418,555.00 -0.9%0.2%3 $4.85 2/28/202287,100 shares $473,824.00 -1.8%0.2%3.4 $5.44 2/15/202288,700 shares $584,905.54 -9.8%0.2%4.7 $6.59 1/31/202298,300 shares $711,692.00 +7.3%0.2%4.9 $7.24 1/15/202291,600 shares $749,746.00 +5.8%0.2%4.6 $8.19 12/31/202186,600 shares $698,723.44 -23.3%0.2%4 $8.07 12/15/2021112,900 shares $1.01 million -20.3%0.3%5.1 $8.99 11/30/2021141,600 shares $1.16 million -1.3%0.4%6.2 $8.22 11/15/2021143,500 shares $1.48 million -3.4%0.4%7 $10.29 10/29/2021148,500 shares $1.67 million -27.5%0.4%7.4 $11.24 10/15/2021204,700 shares $2.39 million -4.3%0.5%8 $11.70 9/30/2021213,900 shares $3.07 million +18.2%0.5%6.6 $14.37 9/15/2021180,900 shares $2.76 million -28.6%0.4%4.8 $15.25 8/31/2021253,500 shares $4.10 million -17.5%0.6%7.1 $16.16 8/13/2021307,100 shares $5.68 million No Change0.7%6.3 $18.50 ADAG Short Interest - Frequently Asked Questions What is Adagene's current short interest? Short interest is the volume of Adagene shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 47,700 shares of ADAG short. 0.13% of Adagene's shares are currently sold short. Learn More on Adagene's current short interest. What is a good short interest ratio for Adagene? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADAG shares currently have a short interest ratio of 1.0. Learn More on Adagene's short interest ratio. What is a good short interest percentage for Adagene? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.13% of Adagene's floating shares are currently sold short. Is Adagene's short interest increasing or decreasing? Adagene saw a decline in short interest in April. As of April 15th, there was short interest totaling 47,700 shares, a decline of 28.7% from the previous total of 66,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Adagene's float size? Adagene currently has issued a total of 47,110,000 shares. Some of Adagene's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adagene currently has a public float of 35,760,000 shares. How does Adagene's short interest compare to its competitors? 0.13% of Adagene's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Adagene: Atyr PHARMA INC (11.66%), Atai Life Sciences (8.91%), Aura Biosciences, Inc. (4.36%), Cryoport, Inc. (5.39%), Monte Rosa Therapeutics, Inc. (16.37%), Phathom Pharmaceuticals, Inc. (21.93%), Cartesian Therapeutics, Inc. (28.47%), 2seventy bio, Inc. (7.96%), Monopar Therapeutics Inc. (1.18%), Aquestive Therapeutics, Inc. (11.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Adagene stock? Short selling ADAG is an investing strategy that aims to generate trading profit from Adagene as its price is falling. ADAG shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adagene? A short squeeze for Adagene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADAG, which in turn drives the price of the stock up even further. How often is Adagene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADAG, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Atyr PHARMA Short Squeeze Atai Life Sciences Short Squeeze Aura Biosciences Short Squeeze Cryoport Short Squeeze Monte Rosa Therapeutics Short Squeeze Phathom Pharmaceuticals Short Squeeze Cartesian Therapeutics Short Squeeze 2seventy bio Short Squeeze Monopar Therapeutics Short Squeeze Aquestive Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADAG) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adagene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADAG Stock Free ADAG Stock Alerts